Susquehanna Fundamental Investments, LLC Puma Biotechnology, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$8.98 - $11.6 $351,773 - $454,406	-39,173 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $14,220 - $20,663	1,516 Added 4.03%	39,173 $381,000
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $214,728 - $334,788	27,600 Added 274.44%	37,657 $386,000
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $95,541 - $112,034	10,057 New	10,057 $101,000

30.5M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $115M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.